OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 155
- +2 vs. Q1 2021
- Portfolio value
- $9.79B
- −$807.5M (−7.6%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PPBTPurple Biotech Ltd. | SPONSORED ADS | 17,712 | $86.0K | <0.1% | −13,706−43.6% | Reduced | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 113,500 | $1.03M | <0.1% | −186,500−62.2% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 557,191 | $3.03M | <0.1% | +557,191 | New | History |
| IFRXInflaRx N.V. | COM | 1,064,118 | $3.16M | <0.1% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 188,704 | $3.22M | <0.1% | +188,704 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 247,240 | $3.63M | <0.1% | +247,240 | New | History |
| ADAGAdagene Inc. | ADS | 275,000 | $3.73M | <0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 450,000 | $4.38M | <0.1% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 64,700 | $5.03M | 0.1% | −135,578−67.7% | Reduced | History |
| OGNOrganon & Co. | Stock | 166,939 | $5.05M | 0.1% | +166,939 | New | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 500,000 | $5.10M | 0.1% | 00.0% | Unchanged | History |
| SBBPStrongbridge Biopharma plc | SHS USD | 1,744,669 | $5.18M | 0.1% | 00.0% | Unchanged | History |
| LUNGPulmonx Corp | COM | 125,000 | $5.51M | 0.1% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 100,000 | $6.03M | 0.1% | +100,000 | New | History |
| RXDXPrometheus Biosciences, Inc. | COM | 250,000 | $6.14M | 0.1% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 362,000 | $6.36M | 0.1% | +362,000 | New | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 500,000 | $6.89M | 0.1% | 00.0% | Unchanged | History |
| OTICOtonomy, Inc. | COM | 3,250,000 | $7.25M | 0.1% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 350,000 | $7.36M | 0.1% | 00.0% | Unchanged | History |
| LABPLandos Biopharma, Inc. | COM | 681,000 | $7.87M | 0.1% | 00.0% | Unchanged | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 350,000 | $7.95M | 0.1% | +350,000 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 300,000 | $7.96M | 0.1% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 433,700 | $8.06M | 0.1% | +83,700+23.9% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 150,000 | $8.20M | 0.1% | 00.0% | Unchanged | History |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 2,520,000 | $8.32M | 0.1% | 00.0% | Unchanged | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 5,193,946 | $8.78M | 0.1% | 00.0% | Unchanged | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,373,849 | $8.93M | 0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 2,118,600 | $9.17M | 0.1% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 111,120 | $9.33M | 0.1% | +92,555+498.5% | Added | History |
| NMTR9 Meters Biopharma, Inc. | COM | 8,565,974 | $9.42M | 0.1% | −17,150,781−66.7% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 1,513,168 | $9.58M | 0.1% | +1,513,168 | New | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $9.71M | 0.1% | – | New | – |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,837,500 | $10.0M | 0.1% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 400,000 | $11.2M | 0.1% | +400,000 | New | History |
| CNVYConvey Health Solutions Holdings, Inc. | COM | 1,000,000 | $11.4M | 0.1% | +1,000,000 | New | History |
| IPSCCentury Therapeutics, Inc. | COM | 407,047 | $11.9M | 0.1% | +407,047 | New | History |
| IMDXInsight Molecular Diagnostics Inc. | COM | 2,100,000 | $12.1M | 0.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 535,714 | $12.2M | 0.1% | +535,714 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,954,800 | $12.3M | 0.1% | 00.0% | Unchanged | – |
| MAPSWM Technology, Inc. | COM | 700,400 | $12.5M | 0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,313,489 | $12.6M | 0.1% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 611,478 | $12.7M | 0.1% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 350,000 | $12.8M | 0.1% | 00.0% | Unchanged | History |
| AMGNAmgen Inc | Stock | 57,100 | $13.9M | 0.1% | −34,400−37.6% | Reduced | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,583,821 | $14.2M | 0.1% | 00.0% | Unchanged | History |
| SYBXSynlogic, Inc. | COM | 3,696,662 | $14.4M | 0.1% | +1,666,666+82.1% | Added | History |
| QUREuniQure N.V. | SHS | 471,174 | $14.5M | 0.1% | −497,905−51.4% | Reduced | History |
| JNCEJounce Therapeutics, Inc. | COM | 2,147,400 | $14.6M | 0.1% | +323,800+17.8% | Added | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,584,845 | $15.5M | 0.2% | 00.0% | Unchanged | – |
| VORVor Biopharma Inc. | COM | 833,333 | $15.5M | 0.2% | 00.0% | Unchanged | History |
| NAUTNautilus Biotechnology, Inc. | COM | 1,546,700 | $15.6M | 0.2% | +1,546,700 | New | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 230,905 | $15.9M | 0.2% | 00.0% | Unchanged | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 1,479,733 | $16.7M | 0.2% | 00.0% | Unchanged | History |
| CTICCti Biopharma Corp | COM | 7,520,600 | $18.8M | 0.2% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,333,801 | $18.8M | 0.2% | +83,800+6.7% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 287,600 | $19.8M | 0.2% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,033,759 | $19.9M | 0.2% | +1,084,711+114.3% | Added | History |
| DMRADamora Therapeutics, Inc. | COM | 4,090,937 | $20.7M | 0.2% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 945,400 | $21.3M | 0.2% | +296,626+45.7% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 2,719,902 | $21.5M | 0.2% | 00.0% | Unchanged | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 8,053,298 | $21.5M | 0.2% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM | 2,711,013 | $21.8M | 0.2% | 00.0% | Unchanged | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 807,792 | $22.6M | 0.2% | +151,666+23.1% | Added | History |
| CALCCalciMedica, Inc. | COM SHS | 4,163,347 | $22.6M | 0.2% | 00.0% | Unchanged | History |
| FLXNFlexion Therapeutics Inc | COM | 2,769,383 | $22.8M | 0.2% | +461,300+20.0% | Added | History |
| BIIBBiogen Inc. | COM | 67,400 | $23.3M | 0.2% | −14,600−17.8% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,334,217 | $24.8M | 0.3% | −1,163,700−46.6% | Reduced | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,224,770 | $26.1M | 0.3% | 00.0% | Unchanged | History |
| APTOAptose Biosciences Inc. | COM NEW | 8,030,000 | $26.7M | 0.3% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 3,070,955 | $27.6M | 0.3% | 00.0% | Unchanged | History |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 150,900 | $27.7M | 0.3% | +48,800+47.8% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM | 4,015,524 | $27.9M | 0.3% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 3,521,400 | $28.4M | 0.3% | −845,094−19.4% | Reduced | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 848,503 | $28.7M | 0.3% | −358,383−29.7% | Reduced | History |
| LABStandard Biotools Inc. | COM | 4,661,871 | $28.7M | 0.3% | +62,300+1.4% | Added | History |
| SRRASierra Oncology, Inc. | COM NEW | 1,477,320 | $28.8M | 0.3% | 00.0% | Unchanged | History |
| KALAKALA BIO, Inc. | COM | 5,465,030 | $29.0M | 0.3% | 00.0% | Unchanged | History |
| SCPHscPharmaceuticals Inc. | COM | 4,797,148 | $29.3M | 0.3% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,146,145 | $29.5M | 0.3% | 00.0% | Unchanged | History |
| GHRSGH Research PLC | ORDINARY SHARES | 1,428,666 | $31.0M | 0.3% | +1,428,666 | New | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 3,322,300 | $32.2M | 0.3% | +157,100+5.0% | Added | – |
| LENZLENZ Therapeutics, Inc. | COM | 1,106,307 | $34.0M | 0.3% | +1,106,307 | New | History |
| NSTGNS Wind Down Co., Inc. | COM | 556,000 | $36.0M | 0.4% | −66,900−10.7% | Reduced | History |
| HARPHarpoon Therapeutics, Inc. | COM | 2,611,308 | $36.2M | 0.4% | +325,604+14.2% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 5,694,841 | $37.2M | 0.4% | 00.0% | Unchanged | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 8,466,783 | $37.6M | 0.4% | 00.0% | Unchanged | – |
| IRONDisc Medicine, Inc. | COM | 5,826,224 | $37.7M | 0.4% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,800,247 | $38.0M | 0.4% | +907,747+48.0% | Added | History |
| SIBNSI-BONE, Inc. | COM | 1,305,300 | $41.1M | 0.4% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,933,941 | $41.2M | 0.4% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,337,574 | $41.4M | 0.4% | 00.0% | Unchanged | History |
| TCDATricida, Inc. | COM | 9,614,280 | $41.5M | 0.4% | 00.0% | Unchanged | History |
| NVAXNovavax Inc | COM NEW | 200,295 | $42.5M | 0.4% | +44,462+28.5% | Added | History |
| DBTXDecibel Therapeutics, Inc. | COM | 4,945,192 | $42.5M | 0.4% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 14,467,872 | $45.6M | 0.5% | +5,863,872+68.2% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 3,791,204 | $46.5M | 0.5% | 00.0% | Unchanged | History |
| APLTApplied Therapeutics, Inc. | COM | 2,257,387 | $46.9M | 0.5% | 00.0% | Unchanged | History |
| TELATELA Bio, Inc. | COM | 3,027,542 | $48.8M | 0.5% | 00.0% | Unchanged | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 2,578,174 | $49.0M | 0.5% | 00.0% | Unchanged | History |
| SEMSelect Medical Holdings Corp | COM | 1,271,100 | $53.7M | 0.5% | +1,271,100 | New | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Curevac N VN2451R105 | COM | $10.3M | $2.20M |
| BSXBoston Scientific Corp | Stock | – | $10.7M |
| WM Technology, Inc.92971A117 | *W EXP 06/16/202 | – | $954.0K |
Sold out since Q1 2021 (20)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| HAEHaemonetics Corp | COM | 852,000 | $94.6M | 0.9% | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 5,501,144 | $54.2M | 0.5% | History |
| MOHMolina Healthcare, Inc. | COM | 162,400 | $38.0M | 0.4% | History |
| Pandion Therapeutics Inc698340106 | COM | 528,229 | $31.7M | 0.3% | – |
| ALHCAlignment Healthcare, Inc. | COM | 800,000 | $17.5M | 0.2% | History |
| TVTXTravere Therapeutics, Inc. | COM | 528,100 | $13.2M | 0.1% | History |
| Olink Hldg AB680710100 | SPONSORED ADS | 300,000 | $10.8M | 0.1% | – |
| LRMRLarimar Therapeutics, Inc. | COM | 617,245 | $9.02M | 0.1% | History |
| HCATHealth Catalyst, Inc. | COM | 179,598 | $8.40M | 0.1% | History |
| NUVBNuvation Bio Inc. | COM CL A | 800,000 | $8.36M | 0.1% | History |
| SGFYSignify Health, Inc. | CL A COM | 225,000 | $6.58M | 0.1% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 72,500 | $5.82M | 0.1% | History |
| TCRRTCR2 Therapeutics Inc. | COM | 249,279 | $5.50M | 0.1% | History |
| FBRXForte Biosciences, Inc. | COM | 159,664 | $5.47M | 0.1% | History |
| INNVInnovAge Holding Corp. | COM | 200,000 | $5.16M | <0.1% | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 127,816 | $4.71M | <0.1% | History |
| SANASana Biotechnology, Inc. | COM | 60,000 | $2.01M | <0.1% | History |
| RNACCartesian Therapeutics, Inc. | COM | 339,169 | $1.53M | <0.1% | History |
| Silver Spike Acquisition CorG8136L114 | *W EXP 08/02/202 | 150,200 | $1.06M | <0.1% | – |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 49,375 | $680.0K | <0.1% | – |